Emerging product-process archetypes in oncology: informing the sustainable provision of next-generation medicines
by Tomás Seosamh Harrington; Jagjit Singh Srai; Ismail Najim
International Journal of Healthcare Technology and Management (IJHTM), Vol. 17, No. 2/3, 2018

Abstract: The emergence of more targeted molecular therapies has contributed to accelerated growth within the oncology market, with forecast spends expected to be circa $74-84 billion by 2018. Coupled with its many specificities around pricing, insurance implications and ethics, we argue that the segment may best inform future pharmaceutical value network design characteristics. Through exploration of future state scenarios and opportunity areas, driven by the adoption of emerging process and digital technologies, a base framework is extended to enable a systematic assessment of candidates that are representative of the wider oncology market. These include niche, low volume drugs on-patent, through to higher volume generics with a history of supply shortages. Oncology 'archetypes' are proposed - classified as 'new niche', 'old niche' and 'established generics' - and applied to develop associated models for reconfiguration, through matching emerging process capabilities to future adaptive supply requirements, and informing the potential for economies of drug 'repurposing'.

Online publication date: Mon, 18-Mar-2019

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Healthcare Technology and Management (IJHTM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com